Sir,

A 53-year-old male patient was admitted to our hospital with alcoholic hepatitis and hepatic encephalopathy. He was mildly confused at the time of admission which precluded a detailed history including medication history. Physical examination revealed a prominent bluish discoloration of his skin with icteric conjunctiva and generalized edema. Pulse and blood pressure were normal and pulse oximetry saturations ranged between 91% and 94% at room temperature. The bluish discoloration was noted over the face, trunk and legs \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. Differential diagnosis considered are enumerated in [Table 1](#T1){ref-type="table"}. Multiple scarred bluish pigmented acneiform lesions were also noted over the back. There was ascites without organomegaly. A blood gas analysis revealed normal oxygen and CO2 levels and methemoglobin content was within normal limits. A detailed review several days later revealed that the patient was taking 100 mg of Minocycline daily for last 3 years for treatment of acne (cumulative dose of approximately 11 grams). His laboratory investigations revealed a normal ceruloplasmin and morning cortisol levels. A liver biopsy excluded hemosiderosis.

![Photograph of the patients face shows a diffuse fixed bluish discoloration over his face, similar discoloration was noted over the entire trunk](JPGM-61-140-g001){#F1}

![A spotted as well as confluent pattern of hyperpigmentation was most prominent over anterior aspect of both legs](JPGM-61-140-g002){#F2}

###### 

Enumerating the differential diagnosis of bluish hyperpigmentation of the skin after exclusion of cyanotic causes

  -------------------------------- ---------------------------------------------------------------------------------------------------------------
  Drug-induced hyperpigmentation   Chloroquine, amiodarone, doxorubicin, phenothiazine, minocycline, bismuth and hydroxychloroquine^\[[@ref1]\]^
  Drug-induced methemoglobinemia   Dapsone, aniline dyes, lidocaine and benzocaine
  Argyria and chrysiasis           Gold and silver toxicity respectively^\[[@ref1]\]^
  Metabolic diseases               Hemochromatosis, alkaptonuria, Addison\'s disease, and Wilson\'s disease
  -------------------------------- ---------------------------------------------------------------------------------------------------------------

A skin biopsy revealed dark, nearly black pigment deposition within macrophages. This again correlated with minocycline-induced hyperpigmentation. Minocycline is a synthetic tetracycline with a prolonged half-life of (*t*1/2 of 15.5 hours). It is used for the treatment of moderate to severe acne and as a disease modifying agent for treatment of rheumatoid arthritis and osteoarthritis. Long-term use of minocycline in cumulative doses of greater than 100 grams have been known to be associated with pigmentation, although smaller doses can also result in mucosal pigmentation.\[[@ref2]\] The prevalence of hyperpigmentation after treatment for 10.5 months among 700 patients was 0.4% at a dose of 100 mg/day and 4% at 200 mg/day.\[[@ref3]\] Another study revealed that 2.4% to 14.8% of patients taking minocycline chronically for acne or rosacea developed hyperpigmentation.\[[@ref4]\] This hyperpigmentation is of three types. Our patient had type II lesions on the legs which are well-circumscribed lesions characteristically seen on healthy skin \[[Figure 2](#F2){ref-type="fig"}\]. Type III is a diffuse hyperpigmentation over sun-exposed areas as seen over the face and these are less likely to respond to laser therapy \[[Figure 1](#F1){ref-type="fig"}\].\[[@ref5]\] Lesions on the back might infrequently appear that resemble Type I lesions developing within acne scars.\[[@ref4]\] Type I lesions are bluish-black macules that develop over acneiform lesions on the face.\[[@ref6]\] Although unclear, possible mechanisms for this pigmentation include siderosis, deposition of insoluble complexes of minocycline or its derivatives chelated to iron, melanin or calcium.\[[@ref4][@ref6]\] The patient was offered Alexandrite™ laser therapy but refused treatment because of his chronic ill health and decompensated alcoholic liver disease. Alexandrite lasers (755-nm), Nd:YAG (532-/1064-nm) and Ruby(694-nm) lasers have been reported to help resolution of all types ofminocycline-induced hyperpigmentation. It is hypothesized that the laser fragments the intracellular and extracellular pigments and aids in their drainage through the lymphatics.\[[@ref7]\] Laser adverse effects are limited to mild desquamation and transient purpura without significant lasting hypopigmentation or scarring.\[[@ref7][@ref8]\] It is important to periodically check for pigmentation among patients on minocycline to prevent cosmetic disfigurement. Estrogen preparations, phenothiazines and amitriptyline that have the propensity to potentiate pigmentation and thus co-therapy is best avoided.\[[@ref9]\] Sunlight has also been known to aggravate hyperpigmentation and sunscreens with high SPF are recommended.\[[@ref10]\]
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